Neutrophils Are a Key Component of the Antitumor Efficacy of Topical Chemotherapy with Ingenol-3-Angelate

Overview of attention for article published in The Journal of Immunology, December 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

patent: 33 patents

Readers on

mendeley: 48 Mendeley

So far, Altmetric has seen 33 patents that reference this research output.

Tiglien-3-one derivatives

Grant US-12208078-B2

United States of America

28 Jan 2025

13-oxidized ingenol derivative and use thereof

Grant US-11753363-B2

United States of America

12 Sep 2023

Tiglien-3-one derivatives

Grant US-10980769-B2

United States of America

20 Apr 2021

Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression…

Grant US-10961538-B2

United States of America

30 Mar 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 29 additional patents.